The Launch Event focused on the BL-B01D1-303 study (hereinafter: 303 Study) led by Chinese scholars. The study evaluated the efficacy and safety of iza-bren for later-line treatment of ...

StemWave shockwave therapy demonstrates success rates between 80-90% for chronic pain sufferers using acoustic wave technology The treatment effectively addresses joint pain, tendonitis, back pain, ...

All In Solutions California has strengthened its intensive outpatient and partial hospitalization programs through the ...

C Health is marking the two-year anniversary of the Child and Adolescent Behavioral Health Grant, which has strengthened prevention, intervention, and treatment efforts for youth and their families ...

Cobb County celebrated recovery at the Drug Treatment Court's BBQ with activities, support, and strong community involvement.

At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing ...

Singer Park Bom expressed his position on the declaration of a complaint against Yang Hyun-suk, YG Entertainment (hereinafter ...

SciSparc Ltd. (Nasdaq: SPRC) ('Company” or 'SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central ...

The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...

Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) gains FDA approval as an add-on maintenance therapy for patients aged 12 and older with inadequately controlled chronic rhinosinusitis with nasal ...

Latest analysis of U.S. real-world evidence demonstrates improved clinical outcomes when cefiderocol is used as earlier ...

Cooler Master's most affordable cooler gets the 3DHP treatment, as they introduce its new and impressive Hyper 212 3DHP Black ...